Dr. J. Paul Monk MD Medical Oncologist

Dr. J. Monk is a medical oncologist in Columbus, Ohio and is affiliated with Ohio State University Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice for 14 years. He is one of 30 doctors at Ohio State University Medical Center who specialize in Medical Oncology.

Are you Dr. J. Monk? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Ohio State University Medical Center
Ranked #20 in Cancer

Education & Medical Training

Riverside Methodist Hospitals/OhioHealth
Residency, Internal Medicine, 1996 - 1999

Ohio State University Hospital
Fellowship, Hematology/Oncology, 1999 - 2002

The Ohio State University College of Medicine
Class of 1996

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

OH State Medical License
Active through 2014

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2012

Publications & Presentations

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
Quinn, D. I.,Tangen, C. M.,Hussain, M.,Lara, P. N.,Goldkorn, A.,Moinpour, C. M.,Garzotto, M. G.,Mack, P. C.,Carducci, M. A.,Monk, J. P.,Twardowski, P. W.,Van Veldhuizen, P. J.,Agarwal, N.,Higano, C. S.,Vogelzang, N. J.,Thompson, I. M.

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: Results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (
Aggarwal, R.,Halabi, S.,Kelly, W. K.,George, D.,Mahoney, J. F.,Millard, F.,Stadler, W. M.,Morris, M. J.,Kantoff, P.,Monk, J. P.,Carducci, M.,Small, E. J.

Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: Results of Cancer and Leukemia Group B (CALGB) 9782.
Monk, J. P., Halabi, S., Picus, J., Hussain, A., Philips, G., Kaplan, E., Ahles, T., Gu, L., Vogelzang, N., Kelly, W. K., Small, E. J.

See all 4 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Cofinity PPO
  • First Health PPO
  • GHI PPO
  • Great West PPO
  • Health Net Arizona HMO
  • Health Net Arizona PPO/POS
  • HealthAmerica HealthAssurance PPO
  • Humana ChoiceCare Network PPO
  • Medical Mutual of Ohio SuperMed Plus
  • Medical Mutual of Ohio SuperMed POS
  • Multiplan PHCS PPO
  • Multiplan PPO
  • MVP Healthcare HMO
  • MVP Healthcare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.